SCHEMBL11816258

SCHEMBL11816258

COc1cccc(CSc2ccc(S(=O)(=O)C(F)(F)F)cc2C(=O)O)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.46
▸ TAS2R14 Q9NYV8 4/20 0.43
▸ APEX1 P27695 1/20 0.43
▸ RAB9A P51151 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA4 P22748 1/20 0.41
▸ CCR2 P41597 1/20 0.41
▸ AKR1C3 P42330 1/20 0.40
▸ EPAS1 Q99814 1/20 0.40
▸ PTPRG P23470 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11818479 0.88 CA2 (0.46) MEN1KMT2AALDH1A1CA2CA4
SCHEMBL11818248 0.86 CA2 (0.43) CYP1A2TAS2R14PTGDR2MEN1KMT2A
SCHEMBL11820018 0.85 CA2 (0.53) CYP1A2MEN1KMT2AALDH1A1CYP3A4
SCHEMBL11821491 0.84 MEN1 (0.45) CYP1A2RAB9AMEN1KMT2AALDH1A1
SCHEMBL11825522 0.83 ALDH1A1 (0.46) CYP1A2MEN1KMT2AKDM4EALDH1A1
SCHEMBL11819449 0.82 CYP1A2 (0.48) CYP1A2APEX1RAB9APTGDR2MEN1
SCHEMBL11816465 0.81 KDM5A (0.41) CA2CA4EPAS1PTPRG
SCHEMBL11817917 0.78 PTPRG (0.47) RAB9AMEN1KMT2AHPGDCA2
SCHEMBL11814899 0.78 PPARD (0.43) CA2CA4EPAS1PTPRG
SCHEMBL11817140 0.78 CA2 (0.42) MEN1KMT2AALDH1A1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 — — US disclosed
Send feedback